As of April 30, 2025, Lipella Pharmaceuticals (LIPO) has a market cap of $6.245 million USD. According to our data, Lipella Pharmaceuticals is ranked No.8960 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $6.24 M |
69.36%
|
Dec 31, 2024 | $3.69 M |
-62.62%
|
Dec 29, 2023 | $9.86 M |
-67.41%
|
Dec 30, 2022 | $30.27 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Abeona Therapeutics
ABEO
|
$0.26 B |
-0.000 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() Merck
MRK
|
$212.01 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
![]() USA
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
![]() UK
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
Market Cap | = | LIPO Stock Price | * | LIPO Shares Outstanding |
= | $2.45 | * | 2.55 M | |
= | $6.24 M |